Cargando…
Disclosure of Genetic Risk Factors for Alzheimer’s Disease to Cognitively Healthy Individuals—From Current Practice towards a Personalised Medicine Scenario
Alzheimer’s disease (AD) is a genetically complex disorder. In addition to the relatively small number of pathogenic variants causing autosomal dominant AD, many others have been associated with the much more common sporadic form. The E4 allele of the Apolipoprotein E (APOE) is the first discovered...
Autores principales: | Galluzzi, Samantha, Pievani, Michela, Zanetti, Orazio, Benussi, Luisa, Frisoni, Giovanni B., Di Maria, Emilio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775740/ https://www.ncbi.nlm.nih.gov/pubmed/36551936 http://dx.doi.org/10.3390/biomedicines10123177 |
Ejemplares similares
-
Genetic counselling and testing for inherited dementia: single-centre evaluation of the consensus Italian DIAfN protocol
por: Mega, Anna, et al.
Publicado: (2020) -
Psychological Impact of Predictive Genetic Testing for Inherited Alzheimer Disease and Frontotemporal Dementia: The IT-DIAfN Protocol
por: Galluzzi, Samantha, et al.
Publicado: (2022) -
Anatomical Substrate and Scalp EEG Markers are Correlated in Subjects with Cognitive Impairment and Alzheimer's Disease
por: Moretti, Davide V., et al.
Publicado: (2011) -
Cognitive and biological effects of citrus phytochemicals in subjective cognitive decline: a 36-week, randomized, placebo-controlled trial
por: Galluzzi, Samantha, et al.
Publicado: (2022) -
Comparison of the effects of transdermal and oral rivastigmine on cognitive function and EEG markers in patients with Alzheimer’s disease
por: Moretti, Davide V., et al.
Publicado: (2014)